Cleo Diagnostics (ASX:COV) Accounts Payable: A$1.01 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:COV Cleo Diagnostics Ltd ASX:COV
10 GF Score
Price A$0.36
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics Accounts Payable?

Cleo Diagnostics ASX:COV -1.39% 10 Accounts Payable is A$1.01 Mil as of Dec. 2025. GuruFocus rates ASX:COV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

Cleo Diagnostics's Accounts Payable for the quarter that ended in Dec. 2025 was A$1.01 Mil.

Cleo Diagnostics's quarterly Accounts Payable increased from Dec. 2024 (A$0.39 Mil) to Jun. 2025 (A$0.87 Mil) and increased from Jun. 2025 (A$0.87 Mil) to Dec. 2025 (A$1.01 Mil).

Cleo Diagnostics's annual Accounts Payable increased from Jun. 2023 (A$0.42 Mil) to Jun. 2024 (A$0.44 Mil) and increased from Jun. 2024 (A$0.44 Mil) to Jun. 2025 (A$0.87 Mil).

Cleo Diagnostics Accounts Payable Related Terms

Cleo Diagnostics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics Accounts Payable Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25
Accounts Payable
0.42 0.44 0.87

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial 0.20 0.44 0.39 0.87 1.01
ASX:COV
10GF Score
Cleo Diagnostics Ltd ASX:COV
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleo Diagnostics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of A$1.01 Mil mean?
Cleo Diagnostics (ASX:COV) has a Accounts Payable of A$1.01 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cleo Diagnostics and its competitors.
Is Cleo Diagnostics' Accounts Payable too high?
Cleo Diagnostics' current Accounts Payable is A$1.01 Mil. Overall, Cleo Diagnostics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' Accounts Payable compare to ABT and SYK?
Cleo Diagnostics' Accounts Payable of A$1.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Cleo Diagnostics and its competitors. Cleo Diagnostics's current Accounts Payable is A$1.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current Accounts Payable of A$1.01 Mil. The current Accounts Payable is A$1.01 Mil. Cleo Diagnostics' overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current Accounts Payable is A$1.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
10GF Score

Get the complete analysis for ASX:COV

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.36
Price